DrugCard

DrugCard is a state-of-the-art, AI-driven platform designed to revolutionize the field of pharmacovigilance. In the highly regulated pharmaceutical industry, monitoring drug safety is a critical yet labor-intensive process. DrugCard addresses these challenges by providing an automated, intelligent system for monitoring, detecting, and managing adverse drug events. It serves as an end-to-end solution for pharmaceutical companies, contract research organizations (CROs), and regulatory affairs professionals, helping them maintain compliance and ensure patient safety with unparalleled efficiency.

The core of DrugCard's innovation lies in its powerful AI engine, which automates the traditionally manual task of screening vast amounts of medical and scientific literature. The system continuously scans global and local databases, scientific journals, and other relevant sources to identify potential Individual Case Safety Reports (ICSRs). This not only saves thousands of hours of manual work but also expands the scope of monitoring, ensuring no critical safety information is missed.

How to use DrugCard

Using DrugCard is a streamlined process designed for pharmacovigilance professionals. First, users configure their account by defining the drug products to be monitored, setting up specific search queries, and selecting the data sources (e.g., PubMed, Embase, local journals). Once configured, the AI engine begins its automated, continuous screening process. Potential adverse event cases identified by the AI are presented in a centralized, user-friendly dashboard. Here, drug safety officers can review the AI-extracted information, validate the findings, and triage cases. For valid cases, the platform assists in processing by automatically populating structured fields for regulatory reporting (compliant with formats like E2B R3). Finally, users can generate comprehensive reports and leverage the analytics dashboard to monitor safety trends and detect emerging signals, ensuring proactive risk management.

Core Features of DrugCard

• AI-Powered Literature Monitoring: Automates the screening of global and local medical literature, identifying mentions of adverse events related to specific drugs with high precision.
• Multi-Source Data Aggregation: Goes beyond traditional literature to monitor a wide range of sources, including congress abstracts and other relevant publications, for a comprehensive safety profile.
• Automated Case Processing: Utilizes Natural Language Processing (NLP) to extract key information from unstructured text and auto-populate ICSRs, significantly reducing manual data entry.
• Advanced Signal Detection: Employs machine learning algorithms to analyze aggregated data, helping to identify new or changing safety signals earlier than traditional methods.
• Regulatory Compliance Engine: Designed to meet global pharmacovigilance standards, including ICH, GVP, and FDA requirements, ensuring all activities are audit-ready.
• Centralized Dashboard and Analytics: Provides a unified, real-time view of all pharmacovigilance activities, with powerful analytics and reporting tools for trend analysis and decision-making.
• Full Audit Trail: Maintains a complete and unalterable record of all user actions and system processes, ensuring full traceability and inspection readiness.

Use Cases for DrugCard

DrugCard is indispensable for various stakeholders in the life sciences industry. Pharmaceutical and biotech companies (MAHs) use it for post-marketing surveillance of their entire product portfolio, ensuring continuous safety monitoring. Contract Research Organizations (CROs) leverage DrugCard to offer more efficient, scalable, and cost-effective pharmacovigilance services to their clients. Regulatory Affairs departments rely on it to ensure timely and accurate reporting to health authorities like the FDA and EMA. Furthermore, medical information teams can use the platform to monitor real-world evidence and patient feedback from a broad spectrum of sources.

Advantages of DrugCard

The primary advantage of DrugCard is the massive gain in operational efficiency, with automation reducing manual screening time by up to 80%. This leads to significant cost savings and allows pharmacovigilance teams to focus on high-value strategic tasks. The platform enhances accuracy by minimizing human error in data extraction and processing. Its comprehensive monitoring capabilities ensure broader safety coverage and improve compliance with stringent regulatory deadlines. By enabling early detection of safety signals, DrugCard facilitates proactive risk management, ultimately enhancing patient safety and protecting public health.

Pricing and Plans

DrugCard operates on a customized enterprise subscription model. The pricing is tailored to the specific needs of each organization, based on factors such as the number of medicinal products being monitored, the volume of literature and data sources screened, and the number of user licenses required. This flexible approach ensures that companies of all sizes can build a plan that fits their scope and budget. For detailed pricing information and a personalized demonstration, prospective clients are encouraged to contact the DrugCard sales team directly.